<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activated leukocytes appear to be directly involved in potentiating ischemic central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) injury </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Adhesion</z:e> of leukocytes to endothelium is essential for their migration and requires the binding of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> receptors of the leukocyte (CD 18) to an intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (ICAM) on endothelium </plain></SENT>
<SENT sid="2" pm="."><plain>Monoclonal antibodies to an ICAM can block leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and transendothelial migration </plain></SENT>
<SENT sid="3" pm="."><plain>To determine the efficacy of anti-ICAM antibody treatment in preserving neurological function after <z:mp ids='MP_0006080'>CNS ischemia</z:mp>, two animal models were used </plain></SENT>
<SENT sid="4" pm="."><plain>A 1-mg/kg dose of anti-ICAM was given to rabbits 30 minutes before induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> either in the spinal cord using temporary aortic occlusion or in the brain using intra-arterial microspheres </plain></SENT>
<SENT sid="5" pm="."><plain>In this study, treatment with anti-ICAM produced a significant reduction in neurological deficits in the reversible <z:e sem="disease" ids="C0752130" disease_type="Disease or Syndrome" abbrv="">spinal cord ischemia</z:e> model but not in the irreversible <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> model </plain></SENT>
<SENT sid="6" pm="."><plain>This protective effect supports the active role of leukocytes in <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> reperfusion ischemic injury and offers potential for future therapy </plain></SENT>
</text></document>